Hong Tang

Switching from entecavir to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: A randomised open-label trial (OSST trial)

Qin Ning, Meifang Han, Yongtao Sun et al. · Journal of Hepatology · 2014 · 279 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

Long-Term Treatment With Entecavir Induces Reversal of Advanced Fibrosis or Cirrhosis in Patients With Chronic Hepatitis B

Eugene R. Schiff, Samuel S. Lee, You‐Chen Chao et al. · Clinical Gastroenterology and Hepatology · 2010 · 193 citations

Medicine, Internal Medicine, Pharmacotherapy +17

Promoter analysis in living zebrafish embryos identifies a cis-acting motif required for neuronal expression of GATA-2

Anming Meng, Hong Tang, Bruce A. Ong et al. · Proceedings of the National Academy of Sciences · 1997 · 182 citations

Life Sciences, Developmental Biology, Genetics +17

Transcriptional regulation of hepatitis B virus by nuclear hormone receptors is a critical determinant of viral tropism

Hong Tang, A. McLachlan · Proceedings of the National Academy of Sciences · 2001 · 180 citations · Full text

Life Sciences, Ecology, Evolutionary Biology +17

HBsAg Loss with Peg-interferon Alfa-2a in Hepatitis B Patients with Partial Response to Nucleos(t)ide Analog: New Switch Study

Peng Hu, Jia Shang, Wenhong Zhang et al. · Journal of Clinical and Translational Hepatology · 2018 · 165 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17